卖什么
Gen-AI Designed Enzymes for Pharmaceutical Innovation
商业模式拆解
触发点：什么让他们现在购买？
Low enzyme activity or costly multi-step chemical synthesis of a drug (e.g. 17 chemical steps) that enzymatic conversion could replace.
工作流：什么输入变成什么输出？
Customer supplies a target reaction or enzyme with low activity; Pando sources/engineers enzymes with AI plus a wet-lab screening platform, delivers variants with FTO and no prior art.
经济账：省了什么，怎么收费？
Custom service/program deals (biocatalysis, DNA-modifying enzyme programs) plus catalog enzyme products; claims cost reduction of 50% and $24M new profit in case studies.
渠道：怎么接触到客户？
Direct BD with founders, conferences (CPHI, ASHG, AMP) and LinkedIn; contact-us form.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2023 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.